Proteostasis regulators
US9556166B2 · kind B2 · utility
7Cited by
27References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2012 |
| Grant date | Jan 31, 2017 |
| Priority date | — |
| Expiry date | Sep 16, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds having the Formulae (Ia-Ie), (II), (IIIa-IIId), (IVa-IVc), (Va-Vb), (VIa-VIe), (VII), (VIIIa-VIIIc), and (IX), pharmaceutically acceptable salts, prodrugs and solvates thereof, compositions of any of thereof and methods for the treatment of a condition associated with a dysfunction in proteostasis comprising an effective amount of these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.